Evidence map›Paper›PMID 40177993›Full record

ArticleEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)2026

The accuracy of administrative data in identifying pulmonary metastases: a population-based study in Northern Italy.

Francesco Marinelli, Maria Barbara Braghiroli, Isabella Bisceglia, Francesca Roncaglia, Annamaria Pezzarossi, Fortunato Morabito, Antonino Neri, Paolo Giorgi Rossi, Lucia Mangone

Abstract read
In one paragraph

Article in European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francesco MarinelliEpidemiology Unit, Azienda USL-IRCCS di Reggio Emilia.
Maria Barbara BraghiroliEpidemiology Unit, Azienda USL-IRCCS di Reggio Emilia.
Isabella BiscegliaEpidemiology Unit, Azienda USL-IRCCS di Reggio Emilia.
Francesca RoncagliaEpidemiology Unit, Azienda USL-IRCCS di Reggio Emilia.
Annamaria PezzarossiEpidemiology Unit, Azienda USL-IRCCS di Reggio Emilia.
Fortunato MorabitoGruppo Amici Dell'Ematologia Foundation-GrADE.
Antonino NeriAzienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Paolo Giorgi RossiEpidemiology Unit, Azienda USL-IRCCS di Reggio Emilia.
Lucia MangoneEpidemiology Unit, Azienda USL-IRCCS di Reggio Emilia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLung cancer remains a highly prevalent and lethal disease, with the majority of tumors identified at advanced stages. Screening with low-dose CT was shown to be effective in reducing mortality through early diagnosis. Administrative data are increasingly utilized in clinical settings and research for identifying metastatic lung cancer, yet their accuracy and limitations require thorough evaluation.

methodsThis study evaluated the use of administrative data to identify lung cancer metastases within the population-based cancer registry (CR) of Reggio Emilia by cross-referencing registry data with administrative hospital discharge records (HDRs). Distant metastases were identified using specific International Classification of Diseases, 9th revision codes, with medical records reviewed to validate and refine the identification process. Standardized incidence and mortality rates were calculated and analyzed using joinpoint regression.

resultsBetween 2018 and 2021, 1391 lung cancers exhibiting at least one HDR were identified. Of these, 383 (27.5%) cases had distant metastases, 80 (6%) had a second tumor, and 12 (1.5%) had unknown tumor sites. After a manual review of cases with codes 196 (secondary and unspecified malignant neoplasm of lymph nodes) and code 199 (malignant neoplasm without specification of the site), the number of identified metastatic tumors increased to 30.5%. Lung cancer metastases identified by the CR showed an HDR sensitivity equal to 32.6%.

conclusionAdministrative data, even with manual verification, achieved a positive predictive value of 30.5 for metastatic tumors. The scientific community and policymakers must be aware of these limitations and the need for additional resources to accurately screen to evaluate lung cancer.

Indexed as

Data AccuracyLung NeoplasmsRegistriesAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansIncidenceItalyMaleMiddle Agedaccuracyadministrative datacancer registrylung cancermetastasespublic health

Identifiers

PMID40177993
PMCPMC12851540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.